New aspects of preleukemic disorders.
Preleukemic disorders are a controversial group of panmyelopathic disturbances that often precede the emergence of acute myeloblastic or myelomonocytic leukemia. In most instances, these preleukemic disorders are characterized by slowly developing myeloblastosis of the bone marrow. They include preleukemia, primary acquired panmyelopathy with myeloblastosis or smouldering acute leukemia, erythroleukemia, and subacute myelomonocytic leukemia. Sometimes, transitions between these various preleukemic disorders may be observed in a single individual. Abnormalities in cellular differentiation are expressed in cytochemical aberrations and in elaboration of colony forming units by marrow cells of patients with preleukemic disorders. Cytogenic and cellular kinetic abnormalities link preleukemic disorders closely to acute myeloblastic or myelomonocytic leukemia, although in many patients with preleukemic disorders, conversion to acute leukemia is not observed or perhaps not recognized. Understanding pathogenetic and pathophysiological aspects of preleukemic disorders may shed light on aspects of cellular proliferation and cellular differentiation in the acute leukemias.
D000208:Acute Disease; D001853:Bone Marrow / Q000473:pathology; D006098:Granulocytes / Q000166:cytology; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000473:pathology / Q000503:physiopathology; D007948:Leukemia, Monocytic, Acute / Q000473:pathology / Q000503:physiopathology*; D015470:Leukemia, Myeloid, Acute / Q000503:physiopathology*; D011289:Preleukemia / Q000473:pathology / Q000503:physiopathology*